Literature DB >> 32226622

Graft-Versus-Host Disease After Liver Transplantation.

Ashley Wood1, Bijan Eghtesad2, Christina C Lindenmeyer3.   

Abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-reading-wood a video presentation of this article http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-interview-lindenmeyer an interview with the author.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2020        PMID： 32226622      PMCID： PMC7098667          DOI： 10.1002/cld.884

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  24 in total

1.  Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease.

Authors:  M Riñón; N Maruri; A Arrieta; J R Fernández; J Ortiz de Urbina; M D García Masdevall
Journal:  Transplant Proc       Date:  2002-02       Impact factor: 1.066

2.  Rapid resolution of GVHD after orthotopic liver transplantation in a patient treated with alefacept.

Authors:  Christy J Stotler; Bijan Eghtesad; Eric Hsi; Bernard Silver
Journal:  Blood       Date:  2009-05-21       Impact factor: 22.113

3.  Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

Authors:  Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele Falda
Journal:  Am J Hematol       Date:  2007-01       Impact factor: 10.047

4.  Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Authors:  A Bacigalupo; T Lamparelli; P Bruzzi; S Guidi; P E Alessandrino; P di Bartolomeo; R Oneto; B Bruno; M Barbanti; N Sacchi; M T Van Lint; A Bosi
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

5.  Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

Authors:  Holly K Miller; Thomas M Braun; Terri Stillwell; Andrew C Harris; Sung Choi; James Connelly; Daniel Couriel; Steven Goldstein; Carrie L Kitko; John Magenau; Attaphol Pawarode; Pavan Reddy; Mary Riwes; Gregory A Yanik; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-22       Impact factor: 5.742

6.  Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation.

Authors:  Xiao-Bo Chen; Jie Yang; Ming-Qing Xu; Tian-Fu Wen; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

7.  Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.

Authors:  Anna L Taylor; Paul Gibbs; Surendran Sudhindran; Tim Key; Reyna S Goodman; C Helen Morgan; Christopher J E Watson; Luc Delriviere; Graeme J Alexander; Neville V Jamieson; J Andrew Bradley; Craig J Taylor
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

8.  Graft-versus-host disease after liver transplantation.

Authors:  Eleazar Chaib; Felipe D Silva; Esteia R R Figueira; Fabiana R Lima; Wellington Andraus; Luiz Augusto C D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation.

Authors:  Joo Han Park; Hyo Jung Lee; Sei Rhan Kim; Ga Won Song; Seung Kyong Lee; Sun Young Park; Ki Chan Kim; Sun Hyuk Hwang; Joon Seong Park
Journal:  Korean J Intern Med       Date:  2014-08-28       Impact factor: 2.884
View more
  1 in total

1.  Acute Graft Versus Host Disease Following Liver Transplantation: Case Report With Review of Current Literature.

Authors:  Kirubakaran K Renganathan; Anand Ramamurthy; Sheeba Jacob; Anil Tharigopula; Anil Vaidya; Mahesh Gopashetty; Anand Khakar
Journal:  J Clin Exp Hepatol       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.